Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mobile medical management with bronchodilator regimens in COPD
ChiCTR2000033901Phase 4Recruiting
- Sponsor
- Shapingba District People's Hospital
- Start
- Jun 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of Anoro Ellipta, tiotropium and salmeterol + fluticasone in chronic obstructive pulmonary disease (COPD) (4 arms), sponsored by Shapingba District People's Hospital. Primary endpoints: Lung function, 6-minute walk test distance and 4 more. Started Jun 2020; status: recruiting.
02
Drugs
Anoro Elliptatiotropiumsalmeterol + fluticasone
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on ChiCTR2000033901.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000033901.